跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,725 条关于
“CD40/CD40L pathway”
全部
7,725
临床试验
2,392
药物
431
机构
14
资讯
4,888
2年前
Eledon's Tegoprubart Shows Promise in Phase 1b Kidney Transplant Trial with Superior Organ Function Preservation
去年
BI655064 Shows Promise in Improving Renal Outcomes in Lupus Nephritis
去年
Type 1 Diabetes Pipeline Shows Robust Growth with 85+ Companies Developing 100+ Therapeutic Candidates
11个月前
Tonix Pharmaceuticals Advances TNX-1500 Anti-CD40L Antibody for Transplant Rejection Prevention
3年前
SEA-CD40 Combo Shows Antitumor Activity in Pancreatic Cancer
去年
Frexalimab Shows Promise in Treating Autoimmune Diseases by Targeting CD40 Ligand
去年
CD40 and CD70 Targeted Therapies Show Promise in Clinical Trials for Cancer and Autoimmune Diseases
上个月
Spero Therapeutics Appoints Dr. Debra Jeske Zack as CMO to Lead Phase 2-Ready Anti-CD40L Antibody SP001
去年
Tegoprubart Successfully Used in Second Pig-to-Human Kidney Xenotransplant at MGH
去年
UCB and Biogen's Dapirolizumab Pegol Shows Promise in Phase 3 Lupus Trial
第 1 页,共 489 页
上一页
下一页